Cargando…
Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294471/ https://www.ncbi.nlm.nih.gov/pubmed/27780194 http://dx.doi.org/10.1038/bjc.2016.347 |
| _version_ | 1782505248996196352 |
|---|---|
| author | Berney, Daniel M |
| author_facet | Berney, Daniel M |
| author_sort | Berney, Daniel M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5294471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52944712018-01-31 Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ Berney, Daniel M Br J Cancer Letter to the Editor Nature Publishing Group 2017-01-31 2016-10-25 /pmc/articles/PMC5294471/ /pubmed/27780194 http://dx.doi.org/10.1038/bjc.2016.347 Text en Copyright © 2017 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Berney, Daniel M Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title | Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title_full | Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title_fullStr | Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title_full_unstemmed | Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title_short | Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| title_sort | reply to ‘comment on “validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294471/ https://www.ncbi.nlm.nih.gov/pubmed/27780194 http://dx.doi.org/10.1038/bjc.2016.347 |
| work_keys_str_mv | AT berneydanielm replytocommentonvalidationofacontemporaryprostatecancergradingsystemusingprostatecancerdeathasoutcome |